479 related articles for article (PubMed ID: 23719966)
1. Biomarkers for early diagnosis of type 2 diabetic nephropathy: a study based on an integrated biomarker system.
Huang M; Liang Q; Li P; Xia J; Wang Y; Hu P; Jiang Z; He Y; Pang L; Han L; Wang Y; Luo G
Mol Biosyst; 2013 Aug; 9(8):2134-41. PubMed ID: 23719966
[TBL] [Abstract][Full Text] [Related]
2. A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate.
Hoek FJ; Kemperman FA; Krediet RT
Nephrol Dial Transplant; 2003 Oct; 18(10):2024-31. PubMed ID: 13679476
[TBL] [Abstract][Full Text] [Related]
3. Assessment of urinary γ-glutamyltransferase and alkaline phosphatase for diagnosis of diabetic nephropathy.
De Carvalho JA; Piva SJ; Hausen BS; Bochi GV; Kaefer M; Coelho AC; Duarte MM; Moresco RN
Clin Chim Acta; 2011 Jul; 412(15-16):1407-11. PubMed ID: 21527256
[TBL] [Abstract][Full Text] [Related]
4. Serum cystatin C advantageous compared with serum creatinine in the detection of mild but not severe diabetic nephropathy.
Christensson AG; Grubb AO; Nilsson JA; Norrgren K; Sterner G; Sundkvist G
J Intern Med; 2004 Dec; 256(6):510-8. PubMed ID: 15554952
[TBL] [Abstract][Full Text] [Related]
5. Cystatin C is not more sensitive than creatinine for detecting early renal impairment in patients with diabetes.
Oddoze C; Morange S; Portugal H; Berland Y; Dussol B
Am J Kidney Dis; 2001 Aug; 38(2):310-6. PubMed ID: 11479157
[TBL] [Abstract][Full Text] [Related]
6. Urinary heme oxygenase-1 as a potential biomarker for early diabetic nephropathy.
Li Z; Xu Y; Liu X; Nie Y; Zhao Z
Nephrology (Carlton); 2017 Jan; 22(1):58-64. PubMed ID: 26733347
[TBL] [Abstract][Full Text] [Related]
7. Clinical and pathological predictors of estimated GFR decline in patients with type 2 diabetes and overt proteinuric diabetic nephropathy.
Mise K; Hoshino J; Ueno T; Hazue R; Sumida K; Hiramatsu R; Hasegawa E; Yamanouchi M; Hayami N; Suwabe T; Sawa N; Fujii T; Hara S; Ohashi K; Takaichi K; Ubara Y
Diabetes Metab Res Rev; 2015 Sep; 31(6):572-81. PubMed ID: 25533683
[TBL] [Abstract][Full Text] [Related]
8. Osteoinductive factor is a novel biomarker for the diagnosis of early diabetic nephropathy.
Wang S; Wang Y; Zheng R; Zhao Z; Ma Y
Int J Clin Exp Pathol; 2015; 8(3):3110-5. PubMed ID: 26045825
[TBL] [Abstract][Full Text] [Related]
9. Modulating effect of atorvastatin on paraoxonase 1 activity in type 2 diabetic Egyptian patients with or without nephropathy.
Abdin AA; Hassanien MA; Ibrahim EA; El-Noeman Sel-D
J Diabetes Complications; 2010; 24(5):325-33. PubMed ID: 19553142
[TBL] [Abstract][Full Text] [Related]
10. The comparison of cystatin C and creatinine as an accurate serum marker in the prediction of type 2 diabetic nephropathy.
Lee BW; Ihm SH; Choi MG; Yoo HJ
Diabetes Res Clin Pract; 2007 Dec; 78(3):428-34. PubMed ID: 17822797
[TBL] [Abstract][Full Text] [Related]
11. Excess renal insufficiency among type 2 diabetic patients with dip-stick positive proteinuria in a tertiary hospital.
Balogun WO; Abbiyesuku FM
Afr J Med Med Sci; 2011 Dec; 40(4):399-403. PubMed ID: 22783692
[TBL] [Abstract][Full Text] [Related]
12. Role of new biomarkers for the diagnosis of nephropathy associated with diabetes type 2.
Żyłka A; Gala-Błądzińska A; Rybak K; Dumnicka P; Drożdż R; Kuśnierz-Cabala B
Folia Med Cracov; 2015; 55(4):21-33. PubMed ID: 26867117
[TBL] [Abstract][Full Text] [Related]
13. Cystatin C improves the diagnosis and stratification of chronic kidney disease, and the estimation of glomerular filtration rate in diabetes.
Rigalleau V; Beauvieux MC; Le Moigne F; Lasseur C; Chauveau P; Raffaitin C; Perlemoine C; Barthe N; Combe C; Gin H
Diabetes Metab; 2008 Nov; 34(5):482-9. PubMed ID: 18703370
[TBL] [Abstract][Full Text] [Related]
14. Hemorheological Approach for Early Detection of Chronic Kidney Disease and Diabetic Nephropathy in Type 2 Diabetes.
Lee S; Lee MY; Nam JS; Kang S; Park JS; Shin S; Ahn CW; Kim KR
Diabetes Technol Ther; 2015 Nov; 17(11):808-15. PubMed ID: 26214546
[TBL] [Abstract][Full Text] [Related]
15. Serum cystatin C in diabetic patients. Not only an indicator for renal dysfunction in patients with overt nephropathy but also a predictor for cardiovascular events in patients without nephropathy.
Ogawa Y; Goto T; Tamasawa N; Matsui J; Tando Y; Sugimoto K; Tomotsune K; Kimura M; Yasujima M; Suda T
Diabetes Res Clin Pract; 2008 Feb; 79(2):357-61. PubMed ID: 17980929
[TBL] [Abstract][Full Text] [Related]
16. Urinary podocalyxin positive-element occurs in the early stage of diabetic nephropathy and is correlated with a clinical diagnosis of diabetic nephropathy.
Ye H; Bai X; Gao H; Li L; Wu C; Sun X; Zhang C; Shen Y; Zhang J; Lu Z
J Diabetes Complications; 2014; 28(1):96-100. PubMed ID: 24075693
[TBL] [Abstract][Full Text] [Related]
17. E-cadherin and periostin in early detection and progression of diabetic nephropathy: epithelial-to-mesenchymal transition.
El-Dawla NMQ; Sallam AM; El-Hefnawy MH; El-Mesallamy HO
Clin Exp Nephrol; 2019 Aug; 23(8):1050-1057. PubMed ID: 31104272
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for progression of renal disease in patient with diabetic nephropathy.
Unsal A; Koc Y; Basturk T; Akgun AO; Sakaci T; Ahbap E
Eur Rev Med Pharmacol Sci; 2012 Jul; 16(7):878-83. PubMed ID: 22953635
[TBL] [Abstract][Full Text] [Related]
19. Early urinary and plasma biomarkers for experimental diabetic nephropathy.
Alter ML; Kretschmer A; Von Websky K; Tsuprykov O; Reichetzeder C; Simon A; Stasch JP; Hocher B
Clin Lab; 2012; 58(7-8):659-71. PubMed ID: 22997966
[TBL] [Abstract][Full Text] [Related]
20. Adipokine zinc-alpha-2-glycoprotein as a novel urinary biomarker presents earlier than microalbuminuria in diabetic nephropathy.
Wang Y; Li YM; Zhang S; Zhao JY; Liu CY
J Int Med Res; 2016 Apr; 44(2):278-86. PubMed ID: 26857862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
